Borui Pharmaceutical reported H1 2026 revenue of 678 mln yuan, up 26.17% YoY,
and net profit attributable to shareholders of 58.93 mln yuan, up 243.17% YoY.
2026-08-30
Borui Pharmaceutical reported H1 2026 revenue of 678 mln yuan, up 26.17% YoY,
and net profit attributable to shareholders of 58.93 mln yuan, up 243.17% YoY.